Purchases and Sales Made in Q2 2023 in Actinium Pharmaceuticals, Inc. (ATNM)
This table provides information about the institutional ownership of Actinium Pharmaceuticals, Inc. (ATNM) during Q2 2023. The information is specifically focused on institutions that hold shares of Actinium Pharmaceuticals, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 09, 2023
Q2 2023
|
Group One Trading, L.P.
Chicago, IL |
SELL
|
- |
-24.3K- 61.15% |
$173K - $228K
|
15.4K
$18.5K
|
|
|
Aug 14, 2023
Q2 2023
|
Two Sigma Investments, LP
New York, NY |
SELL
|
- |
-26.1K- 57.25% |
$186K - $245K
|
19.5K
$23.4K
|
|
|
Aug 14, 2023
Q2 2023
|
J. Goldman & CO LP
New York, NY |
SELL
|
- |
-28.7K- 68.03% |
$205K - $270K
|
13.5K
$16.2K
|
|
|
Aug 14, 2023
Q2 2023
|
Morgan Stanley
New York, NY |
SELL
|
- |
-40K- 40.07% |
$286K - $376K
|
59.9K
$71.8K
|
|
|
Aug 10, 2023
Q2 2023
|
Citigroup Inc
|
SELL
|
- |
-42.1K- 84.45% |
$301K - $395K
|
7.75K
$9.3K
|
|
|
Aug 14, 2023
Q2 2023
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
SELL
|
- |
-49K- 36.56% |
$350K - $460K
|
85K
$102K
|
|
|
Aug 03, 2023
Q2 2023
|
Barclays PLC
London, X0 |
SELL
|
- |
-50.5K- 90.68% |
$361K - $474K
|
5.19K
$6.22K
|
|
|
Aug 11, 2023
Q2 2023
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-53.9K- 52.74% |
$385K - $506K
|
48.3K
$58K
|
|
|
May 14, 2024
Q2 2023
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-79.2K- 85.03% |
$566K - $743K
|
13.9K
$16.7K
|
|
|
Aug 14, 2023
Q2 2023
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-79.2K- 85.03% |
$566K - $743K
|
13.9K
$16.7K
|
|
|
Aug 14, 2023
Q2 2023
|
Jane Street Group, LLC
New York, NY |
SELL
|
- |
-114K- 91.48% |
$813K - $1.07M
|
10.6K
$12.7K
|
|
|
Aug 11, 2023
Q2 2023
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
- |
-178K- 72.58% |
$1.27M - $1.67M
|
67.1K
$80.6K
|